Perioperative Considerations of Patients with Pulmonary Hypertension

Liu, Henry; Kalarickal, Philip L.; Tong, Yiwei; Inui, Daisuke; Yarborough, Michael J.; Mathew, Kavitha A.; Gelineau, Amanda; Kaye, Alan D.; Fox, Charles J.

doi:10.5772/56056

Cited by 3 publications

(1 citation statement)

References 104 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hipertensi pulmonal merupakan penyakit yang berpotensi mengancam nyawa dan merupakan akibat dari kelompok penyakit yang heterogen, akan tetapi semuanya memiliki gejala umum peningkatan tekanan di arteri pulmonalis. 11,12 Penyakit-penyakit ini ditandai dengan perjalanan yang progresif dan prognosis yang buruk bagi pasien. Untuk mendiagnosis hipertensi pulmonal (PH), perlu dilakukan pengukuran tekanan arteri pulmonal rata-rata (mPAP) selama kateterisasi jantung kanan.…”

Section: Definisiunclassified

Manajemen Anestesi pada Pasien Obstetri dengan Kelainan Jantung Kongenital dan Risiko Hipertensi Pulmonal

Hartono

Rahardjo

2023

JAOI

View full text Add to dashboard Cite

Jumlah ibu hamil dengan penyakit jantung saat ini meningkat tajam dikarenakan perbaikan daya tahan anak- anak yang lahir dengan masalah penyakit jantung kongenital. Hal ini dapat meningkatkan frekuensi faktor risiko kardiovaskular pada wanita usia subur dan penyakit kardiovaskular merupakan penyebab tersering kematian maternal di negara berkembang. Perubahan kardiovaskular selama kehamilan menambah beban dari penyakit pada ibu hamil dengan penyakit jantung dan dapat meningkatkan kejadian morbiditas dan mortalitas peripartum. Kehamilan merupakan problematika terkait kardiovaskular pada ibu hamil dengan hipertensi pulmonal. Perubahan anatomis dan fisiologis kardiovaskular selama kehamilan serta kelainan patologis jantung yang dimiliki harus menjadi pertimbangan dalam memilih mode persalinan dan pembiusan. Fase kritis terjadi pada saat persalinan dan pascapersalinan. Kondisi yang harus diperhatikan adalah menghindari peningkatan tahanan vaskular pulmonal, penurunan systemic vascular resistance (SVR), kelebihan cairan, nyeri, dan mencegah terjadinya sindrom Eisenmenger serta gagal jantung kanan.

show abstract

Section: Definisiunclassified

Manajemen Anestesi pada Pasien Obstetri dengan Kelainan Jantung Kongenital dan Risiko Hipertensi Pulmonal

Hartono

Rahardjo

2023

JAOI

View full text Add to dashboard Cite

show abstract

Perioperative Management of Pulmonary Hypertension

Nazarnia

2016

Anesthesia and Perioperative Care for Organ Transplantation

View full text Add to dashboard Cite

Minimally invasive or noninvasive cardiac output measurement: an update

et al. 2016

View full text Add to dashboard Cite

Although cardiac output (CO) by pulmonary artery catheterization (PAC) has been an important guideline in clinical management for more than four decades, some studies have questioned the clinical efficacy of CO in certain patient populations. Further, the use of CO by PAC has been linked to numerous complications including dysrhythmia, infection, rupture of pulmonary artery, injury to adjacent arteries, embolization, pulmonary infarction, cardiac valvular damage, pericardial effusion, and intracardiac catheter knotting. The use of PAC has been steadily declining over the past two decades. Minimally invasive and noninvasive CO monitoring have been studied in the past two decades with some evidence of efficacy. Several different devices based on pulse contour analysis are available currently, including the uncalibrated FloTrac/Vigileo system and the calibrated PiCCO and LiDCO systems. The pressure-recording analytical method (PRAM) system requires only an arterial line and is commercially available as the MostCare system. Transesophageal echocardiography (TEE) can measure CO by non-Doppler- or Doppler-based methods. The partial CO2 rebreathing technique, another method to measure CO, is marketed by Novametrix Medical Systems as the NICO system. Thoracic electrical bioimpedance (TEB) and electric bioreactance (EB) are totally noninvasive CO monitoring. Nexfin HD and the newer ClearSight systems are examples of noninvasive CO monitoring devices currently being marketed by Edwards Lifesciences. The developing focus in CO monitoring devices appears to be shifting to tissue perfusion and microcirculatory flow and aimed more at markers that indicate the effectiveness of circulatory and microcirculatory resuscitations.

show abstract

Perioperative Considerations of Patients with Pulmonary Hypertension

Cited by 3 publications

References 104 publications

Manajemen Anestesi pada Pasien Obstetri dengan Kelainan Jantung Kongenital dan Risiko Hipertensi Pulmonal

Manajemen Anestesi pada Pasien Obstetri dengan Kelainan Jantung Kongenital dan Risiko Hipertensi Pulmonal

Perioperative Management of Pulmonary Hypertension

Minimally invasive or noninvasive cardiac output measurement: an update

Contact Info

Product

Resources

About